Kimberly Ann Casarotti, NP
Nurse Practitioner · Petaluma
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 3
- Since medical school
- 9 years
- Graduated 2017
Offices
3 locations · Urgent Care Plus Telehealth Inc · Providence Medical Foundation
Looking this up.
Hospitals listed: Petaluma Valley Hospital · Providence Santa Rosa Memorial Hospital · Sonoma Valley Hospital. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Kimberly Ann Casarotti’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Petaluma Valley HospitalPetaluma, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Providence Santa Rosa Memorial HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
- Sonoma Valley HospitalSonoma, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Petaluma Valley Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 6 the same, 1 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.31 (0.23 to 2.39) · 147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.44 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 49 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.6 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 154 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.7 · 57 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 533 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,427 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,398 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.64 to 5.65) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.56 to 3.98) · 202 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.61 (0 to 18.36) · 49 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.16 (0.85 to 9.47) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 45 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.37 (0 to 1.41) · 1,184 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 6.1 · 26 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.308 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.6 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -3 · 143 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 131 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 26 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 52 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (9.8 to 17.8) · 364 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 138 cases | No different | Jan 2024 – Dec 2024 |
What patients said (246 patients answered, 23% of those asked)
| Cleanliness | 5 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 85% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Providence Santa Rosa Memorial Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.26 to 2.13) · 1,736 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.48 to 1.03) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.27 (137.92 to 224.62) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 245 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,733 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 8,115 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,057 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.37 (0.56 to 4.18) · 2,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0.1 to 3.08) · 772 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.9 to 3.63) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.74 (0.06 to 11.42) · 810 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.04 (0.53 to 7.55) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.8 (0.38 to 3.21) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1) · 7,051 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 77 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.552 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.297 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.353 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.4 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.4 · 580 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 456 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 431 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.9 to 8.3) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (8.2 to 12.7) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.8 to 16.7) · 2,810 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 780 cases | No different | Jan 2024 – Dec 2024 |
What patients said (473 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Sonoma Valley Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 6 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.11 (0.63 to 1.6) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 37 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.6 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 35 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.6 · 345 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 713 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 660 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.36 (0.77 to 5.94) · 101 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.38) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.58 to 4.03) · 100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.86 (0 to 18.76) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (0.84 to 9.45) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.12 (0 to 2.33) · 540 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 60 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 15.5 · 47 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 105 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.2 to 17.9) · 486 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 83 cases | No different | Jan 2024 – Dec 2024 |
What patients said (164 patients answered, 31% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 85% |
| Doctors "always" communicated well | 88% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 84% |
| Doctors "always" listened carefully | 88% |
| Doctors "always" treated them with courtesy and respect | 92% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 81% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$67,560
Medicare paid this office $67,560 for 355 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, denosumab, 1 mg | 18 | $21,627 | None |
| Short return visit (20+ min) | 204 | $17,861 | $62 |
| Return visit (30+ min) | 136 | $15,071 | $87 |
| Telephone medical discussion with physician, 5-10 minutes | 80 | $4,217 | $40 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $1,342 | $64 |
See all 11 services
| Injection, denosumab, 1 mg | 18 | $21,627 | None |
| Short return visit (20+ min) | 204 | $17,861 | $62 |
| Return visit (30+ min) | 136 | $15,071 | $87 |
| Telephone medical discussion with physician, 5-10 minutes | 80 | $4,217 | $40 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $1,342 | $64 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,323 | $120 |
| New patient visit (30+ min) | 12 | $761 | $63 |
| Administration of influenza virus vaccine | 14 | $492 | $35 |
| Injection of drug or substance under skin or into muscle | 22 | $249 | $11 |
| Removal of impacted ear wax by washing | 12 | $169 | $12 |
| Automated urinalysis test | 35 | $81 | $2 |
Procedures Medicare counted
| Removal of tissue | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of impacted ear wax by washing | – | – | 12 | 24 | – | 14 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
355 Original Medicare patients in 2024. Average age 77 · Under 65 4% · 85 and older 19% · Women 67% · Also on Medicaid 9% · Health risk score 1.17. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 64% · Coronary heart disease 28% · Chronic kidney disease 22% · Depression 21% · Diabetes 18% · Heart failure 18% · Cancer 18% · Atrial fibrillation 18% · COPD 13% · Stroke 8% · Dementia 5%.
The office billed $300,886, Medicare allowed $88,273 and paid $67,560; for 2,056 services of 33 kinds; $24,620 of it was for drugs given in the office and $42,940 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 355 | 2,056 | 77 | 1.17 | $300,886 | $67,560 |
| 2023 | 88 | 128 | 79 | 1.04 | $28,637 | $6,507 |
| 2022 | 192 | 370 | 79 | 1.12 | $83,311 | $19,932 |
| 2021 | 137 | 199 | 76 | 1.30 | $46,401 | $11,122 |
| 2020 | 96 | 99 | 73 | 1.17 | $20,754 | $6,624 |
| 2019 | 20 | 35 | 79 | 0.98 | $2,522 | $1,138 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Short return visit (20+ min) | 67 | $4,540 | $55 |
2022: 5 services
| Short return visit (20+ min) | 145 | $11,828 | $58 |
| Return visit (30+ min) | 33 | $3,213 | $85 |
| Telephone medical discussion with physician, 5-10 minutes | 42 | $2,610 | $44 |
| Removal of impacted ear wax by washing | 20 | $297 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $119 | $9 |
2021: 5 services
| Short return visit (20+ min) | 70 | $5,391 | $65 |
| New patient visit (30+ min) | 43 | $1,932 | $45 |
| Return visit (30+ min) | 19 | $1,913 | $83 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $551 | $39 |
| Removal of impacted ear wax by washing | 12 | $150 | $13 |
2020: 2 services
| New patient visit (30+ min) | 73 | $5,344 | $73 |
| Short return visit (20+ min) | 16 | $722 | $45 |
Medicaid work
$1,204 in 2020
Medicaid paid $1,204 for 16 billed services this clinician did in 2020, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (30+ min) | 16 | $1,204 |
| 2020 | 16 | 1 | 16 | $1,204 |
Drugs they prescribed that Part D paid
$184,046
Pharmacies billed $184,046 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (44 of 1,845) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
1,621 generic and 213 brand-name prescriptions · $184,046 in drug cost · 174 antibiotic prescriptions to 130 people · 18 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 31 | $26,971 | $870 |
| Xarelto | 11 | $14,402 | $1,309 |
| Atorvastatin | 101 | $923 | $9 |
| Gabapentin | 31 | $802 | $26 |
| Levothyroxine | 59 | $695 | $12 |
See all 48 drugs
| Eliquis | 31 | $26,971 | $870 |
| Xarelto | 11 | $14,402 | $1,309 |
| Atorvastatin | 101 | $923 | $9 |
| Gabapentin | 31 | $802 | $26 |
| Levothyroxine | 59 | $695 | $12 |
| Fluticasone Propionate | 38 | $673 | $18 |
| Metoprolol | 30 | $597 | $20 |
| Tamsulosin | 27 | $538 | $20 |
| Rosuvastatin | 45 | $507 | $11 |
| Benazepril | 27 | $420 | $16 |
| Omeprazole | 23 | $412 | $18 |
| Amlodipine Besylate | 46 | $410 | $9 |
| Valsartan | 11 | $408 | $37 |
| Simvastatin | 41 | $395 | $10 |
| Celecoxib | 13 | $345 | $27 |
| Losartan | 49 | $335 | $7 |
| Clopidogrel | 17 | $318 | $19 |
| Potassium Chloride | 14 | $298 | $21 |
| Metformin | 28 | $287 | $10 |
| Nystatin | 15 | $285 | $19 |
| Pantoprazole | 29 | $285 | $10 |
| Albuterol Sulfate Hfa | 18 | $281 | $16 |
| Lisinopril | 59 | $280 | $5 |
| Amoxicillin-Clavulanate Potass | 35 | $267 | $8 |
| Atenolol | 21 | $220 | $10 |
| Carvedilol | 15 | $218 | $15 |
| Nitrofurantoin Mono-Macro | 21 | $208 | $10 |
| Allopurinol | 15 | $207 | $14 |
| Quetiapine | 12 | $204 | $17 |
| Doxycycline Hyclate | 23 | $161 | $7 |
| Hydrocodone-Acetaminophen | 19 | $160 | $8 |
| Cephalexin | 31 | $157 | $5 |
| Furosemide | 25 | $155 | $6 |
| Escitalopram | 18 | $153 | $9 |
| Trazodone | 21 | $136 | $6 |
| Clonazepam | 11 | $115 | $10 |
| Alendronate | 12 | $115 | $10 |
| Glipizide | 12 | $111 | $9 |
| Alprazolam | 27 | $97 | $4 |
| Zolpidem | 15 | $90 | $6 |
| Lorazepam | 21 | $89 | $4 |
| Warfarin | 12 | $82 | $7 |
| Prednisone | 17 | $64 | $4 |
| Azithromycin | 28 | $58 | $2 |
| Diazepam | 11 | $37 | $3 |
| Tramadol | 13 | $35 | $3 |
| Hydrochlorothiazide | 12 | $33 | $3 |
| Paxlovid | 14 | $0 | $0 |
Year by year
| 2024 | 1,845 | 568 | 2% (44) | 12% | $184,046 |
| 2023 | 2,244 | 382 | 1% (23) | 12% | $286,901 |
| 2022 | 2,541 | 419 | 3% (70) | 12% | $349,220 |
| 2021 | 1,175 | 356 | 4% (48) | None | $143,420 |
| 2020 | 1,227 | 332 | 1% (14) | None | $122,474 |
| 2019 | 1,596 | 347 | 7% (109) | None | $122,981 |
| 2018 | 172 | 87 | None | 11% | $10,145 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 57 drugs
| Eliquis | 27 | $41,241 | $1,527 |
| Descovy | 12 | $28,270 | $2,356 |
| Januvia | 11 | $16,496 | $1,500 |
| Xarelto | 12 | $14,585 | $1,215 |
| Symbicort | 28 | $11,302 | $404 |
| Spiriva Respimat | 17 | $11,058 | $650 |
| Lantus | 16 | $5,113 | $320 |
| Wixela Inhub | 17 | $2,494 | $147 |
| Atorvastatin | 166 | $2,140 | $13 |
| Levothyroxine | 104 | $2,087 | $20 |
| Losartan | 79 | $1,472 | $19 |
| Albuterol Sulfate Hfa | 33 | $1,091 | $33 |
| Rosuvastatin | 46 | $1,002 | $22 |
| Benazepril | 46 | $1,001 | $22 |
| Lisinopril | 90 | $852 | $9 |
| Tamsulosin | 45 | $773 | $17 |
| Amlodipine Besylate | 87 | $750 | $9 |
| Gabapentin | 26 | $681 | $26 |
| Allopurinol | 24 | $664 | $28 |
| Metformin | 57 | $659 | $12 |
| Pantoprazole | 38 | $651 | $17 |
| Celecoxib | 18 | $643 | $36 |
| Doxycycline Hyclate | 20 | $643 | $32 |
| Simvastatin | 52 | $546 | $10 |
| Propranolol | 13 | $510 | $39 |
| Metoprolol | 34 | $496 | $15 |
| Fenofibrate | 13 | $491 | $38 |
| Potassium Chloride | 15 | $459 | $31 |
| Furosemide | 47 | $436 | $9 |
| Glipizide | 14 | $426 | $30 |
| Carvedilol | 26 | $406 | $16 |
| Clopidogrel | 24 | $385 | $16 |
| Omeprazole | 27 | $367 | $14 |
| Atenolol | 26 | $321 | $12 |
| Fluticasone Propionate | 19 | $319 | $17 |
| Nitrofurantoin Mono-Macro | 16 | $301 | $19 |
| Spironolactone | 20 | $269 | $13 |
| Trazodone | 15 | $248 | $17 |
| Escitalopram | 18 | $246 | $14 |
| Finasteride | 15 | $224 | $15 |
| Alendronate | 15 | $220 | $15 |
| Metoprolol | 25 | $203 | $8 |
| Montelukast | 15 | $202 | $13 |
| Clonazepam | 18 | $199 | $11 |
| Lovastatin | 12 | $169 | $14 |
| Tramadol | 12 | $140 | $12 |
| Fluoxetine | 16 | $139 | $9 |
| Warfarin | 14 | $138 | $10 |
| Hydrochlorothiazide | 30 | $126 | $4 |
| Amoxicillin-Clavulanate Potass | 11 | $124 | $11 |
| Cephalexin | 18 | $109 | $6 |
| Prednisone | 14 | $91 | $7 |
| Lorazepam | 15 | $75 | $5 |
| Azithromycin | 14 | $75 | $5 |
| Ciprofloxacin | 13 | $72 | $6 |
| Pregabalin | 12 | $37 | $3 |
| Glimepiride | 12 | $10 | $1 |
2022: 63 drugs
| Eliquis | 22 | $35,535 | $1,615 |
| Xarelto | 20 | $22,084 | $1,104 |
| Januvia | 11 | $14,581 | $1,326 |
| Novolin 70-30 | 17 | $4,868 | $286 |
| Wixela Inhub | 11 | $4,363 | $397 |
| Atorvastatin | 193 | $2,956 | $15 |
| Levothyroxine | 116 | $2,498 | $22 |
| Losartan | 125 | $2,067 | $17 |
| Olanzapine | 11 | $1,757 | $160 |
| Rosuvastatin | 49 | $1,542 | $31 |
| Tamsulosin | 73 | $1,510 | $21 |
| Albuterol Sulfate Hfa | 42 | $1,395 | $33 |
| Gabapentin | 39 | $1,392 | $36 |
| Amlodipine Besylate | 120 | $1,177 | $10 |
| Hydrocodone-Acetaminophen | 46 | $953 | $21 |
| Doxycycline Hyclate | 11 | $939 | $85 |
| Metoprolol | 38 | $870 | $23 |
| Pantoprazole | 47 | $840 | $18 |
| Allopurinol | 28 | $776 | $28 |
| Lisinopril | 100 | $772 | $8 |
| Potassium Chloride | 24 | $725 | $30 |
| Nifedipine Er | 11 | $717 | $65 |
| Pregabalin | 16 | $692 | $43 |
| Omeprazole | 45 | $650 | $14 |
| Benazepril | 43 | $631 | $15 |
| Fenofibrate | 13 | $616 | $47 |
| Alendronate | 30 | $615 | $21 |
| Simvastatin | 49 | $595 | $12 |
| Clopidogrel | 37 | $595 | $16 |
| Ezetimibe | 14 | $556 | $40 |
| Valsartan | 11 | $522 | $47 |
| Carvedilol | 35 | $518 | $15 |
| Bupropion Xl | 14 | $452 | $32 |
| Finasteride | 25 | $439 | $18 |
| Propranolol | 12 | $406 | $34 |
| Losartan-Hydrochlorothiazide | 12 | $401 | $33 |
| Pravastatin | 18 | $400 | $22 |
| Duloxetine | 13 | $390 | $30 |
| Metformin | 34 | $357 | $11 |
| Fluticasone Propionate | 21 | $347 | $17 |
| Furosemide | 35 | $320 | $9 |
| Doxazosin Mesylate | 15 | $314 | $21 |
| Spironolactone | 18 | $313 | $17 |
| Montelukast | 14 | $297 | $21 |
| Escitalopram | 20 | $294 | $15 |
| Metoprolol | 31 | $283 | $9 |
| Triamterene-Hydrochlorothiazid | 14 | $237 | $17 |
| Hydrochlorothiazide | 22 | $236 | $11 |
| Warfarin | 11 | $212 | $19 |
| Fluoxetine | 16 | $187 | $12 |
| Prednisone | 12 | $184 | $15 |
| Atenolol | 16 | $166 | $10 |
| Trazodone | 17 | $147 | $9 |
| Tramadol | 15 | $120 | $8 |
| Lovastatin | 14 | $110 | $8 |
| Sertraline | 14 | $105 | $7 |
| Lorazepam | 18 | $99 | $5 |
| Temazepam | 13 | $96 | $7 |
| Cyclobenzaprine | 11 | $90 | $8 |
| Meloxicam | 18 | $77 | $4 |
| Alprazolam | 20 | $65 | $3 |
| Clonazepam | 16 | $22 | $1 |
| Glimepiride | 11 | $9 | $1 |
2021: 30 drugs
| Eliquis | 11 | $12,846 | $1,168 |
| Wixela Inhub | 16 | $6,220 | $389 |
| Flovent Hfa | 16 | $5,989 | $374 |
| Suprep | 24 | $2,692 | $112 |
| Levothyroxine | 47 | $1,256 | $27 |
| Duloxetine | 16 | $1,048 | $65 |
| Losartan | 48 | $814 | $17 |
| Atorvastatin | 68 | $769 | $11 |
| Omeprazole | 23 | $606 | $26 |
| Gabapentin | 23 | $596 | $26 |
| Pantoprazole | 28 | $566 | $20 |
| Hydrocodone-Acetaminophen | 32 | $537 | $17 |
| Tamsulosin | 27 | $524 | $19 |
| Metoprolol | 21 | $464 | $22 |
| Venlafaxine Hcl Er | 14 | $433 | $31 |
| Clopidogrel | 14 | $407 | $29 |
| Benazepril | 31 | $381 | $12 |
| Finasteride | 14 | $358 | $26 |
| Simvastatin | 29 | $342 | $12 |
| Amlodipine Besylate | 23 | $270 | $12 |
| Rosuvastatin | 13 | $264 | $20 |
| Famotidine | 11 | $245 | $22 |
| Lisinopril | 48 | $241 | $5 |
| Allopurinol | 11 | $182 | $17 |
| Furosemide | 18 | $158 | $9 |
| Metformin | 11 | $142 | $13 |
| Hydrochlorothiazide | 11 | $107 | $10 |
| Cephalexin | 13 | $76 | $6 |
| Temazepam | 13 | $74 | $6 |
| Lorazepam | 11 | $28 | $3 |
2020: 35 drugs
| Lantus Solostar | 13 | $12,395 | $953 |
| Wixela Inhub | 13 | $4,295 | $330 |
| Flovent Hfa | 12 | $4,102 | $342 |
| Suprep | 24 | $2,520 | $105 |
| Levothyroxine | 65 | $1,786 | $27 |
| Celecoxib | 20 | $1,201 | $60 |
| Metoprolol | 25 | $990 | $40 |
| Rosuvastatin | 20 | $967 | $48 |
| Atorvastatin | 43 | $791 | $18 |
| Omeprazole | 25 | $756 | $30 |
| Tamsulosin | 29 | $710 | $24 |
| Gabapentin | 27 | $610 | $23 |
| Venlafaxine Hcl Er | 15 | $568 | $38 |
| Potassium Chloride | 14 | $546 | $39 |
| Losartan | 33 | $503 | $15 |
| Simvastatin | 38 | $479 | $13 |
| Benazepril | 29 | $436 | $15 |
| Bupropion Xl | 11 | $412 | $37 |
| Albuterol Sulfate Hfa | 11 | $388 | $35 |
| Finasteride | 14 | $379 | $27 |
| Doxazosin Mesylate | 20 | $366 | $18 |
| Metformin | 30 | $342 | $11 |
| Lisinopril | 47 | $309 | $7 |
| Amlodipine Besylate | 19 | $248 | $13 |
| Meloxicam | 16 | $247 | $15 |
| Peg 3350-Electrolyte | 16 | $240 | $15 |
| Allopurinol | 15 | $182 | $12 |
| Furosemide | 17 | $140 | $8 |
| Metformin Hcl Er | 14 | $137 | $10 |
| Escitalopram | 15 | $117 | $8 |
| Clonidine | 13 | $114 | $9 |
| Hydrochlorothiazide | 14 | $108 | $8 |
| Hydralazine | 12 | $76 | $6 |
| Isosorbide Mononitrate | 12 | $52 | $4 |
| Mirtazapine | 12 | $24 | $2 |
2019: 50 drugs
| Lantus Solostar | 11 | $10,615 | $965 |
| Eliquis | 14 | $8,601 | $614 |
| Flovent Hfa | 15 | $4,127 | $275 |
| Atorvastatin | 78 | $1,842 | $24 |
| Bystolic | 11 | $1,591 | $145 |
| Levothyroxine | 56 | $1,444 | $26 |
| Hydrocodone-Acetaminophen | 77 | $1,413 | $18 |
| Gabapentin | 39 | $1,376 | $35 |
| Rosuvastatin | 14 | $1,051 | $75 |
| Oxycodone-Acetaminophen | 15 | $1,043 | $70 |
| Metoprolol | 18 | $1,036 | $58 |
| Potassium Chloride | 21 | $829 | $39 |
| Tamsulosin | 23 | $666 | $29 |
| Omeprazole | 18 | $627 | $35 |
| Simvastatin | 33 | $559 | $17 |
| Montelukast | 24 | $552 | $23 |
| Finasteride | 18 | $505 | $28 |
| Warfarin | 15 | $485 | $32 |
| Benazepril | 30 | $468 | $16 |
| Venlafaxine Hcl Er | 18 | $463 | $26 |
| Doxazosin Mesylate | 15 | $447 | $30 |
| Diclofenac | 12 | $420 | $35 |
| Lisinopril | 39 | $393 | $10 |
| Duloxetine | 13 | $393 | $30 |
| Losartan | 30 | $378 | $13 |
| Metformin | 34 | $363 | $11 |
| Amlodipine Besylate | 19 | $322 | $17 |
| Metformin Hcl Er | 17 | $320 | $19 |
| Lorazepam | 47 | $313 | $7 |
| Doxepin | 16 | $311 | $19 |
| Sertraline | 15 | $308 | $21 |
| Trazodone | 15 | $221 | $15 |
| Alendronate | 15 | $220 | $15 |
| Zolpidem | 25 | $197 | $8 |
| Azithromycin | 22 | $180 | $8 |
| Meloxicam | 19 | $160 | $8 |
| Alprazolam | 13 | $160 | $12 |
| Hydrochlorothiazide | 22 | $158 | $7 |
| Fluticasone Propionate | 15 | $153 | $10 |
| Temazepam | 15 | $148 | $10 |
| Tramadol | 16 | $135 | $8 |
| Allopurinol | 17 | $133 | $8 |
| Mirtazapine | 11 | $131 | $12 |
| Furosemide | 34 | $129 | $4 |
| Carvedilol | 12 | $108 | $9 |
| Triamterene-Hydrochlorothiazid | 11 | $98 | $9 |
| Atenolol | 11 | $70 | $6 |
| Clonidine | 16 | $60 | $4 |
| Escitalopram | 13 | $47 | $4 |
| Prednisone | 12 | $33 | $3 |
2018: 1 drug
| Fluticasone Propionate | 17 | $193 | $11 |
Money from drug and device companies
$300 in 2025
| 2025 | 5 | 7 | None | $300 |
| 2023 | 2 | 3 | None | $58 |
| 2022 | 3 | 5 | None | $96 |
| 2021 | 2 | 6 | None | $103 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Evenity | $154 | 2 payments
|
| Otsuka America Pharmaceutical | Rexulti | $64 | 2 payments
|
| Lilly USA | Mounjaro | $29 | 1 payment
|
| Astellas Pharma US | Veozah | $28 | 1 payment
|
| Sumitomo Pharma America | Gemtesa | $25 | 1 payment
|
See all 7 published payments
| Otsuka America Pharmaceutical | Meals · 2025-11-04 | Rexulti | $34 |
| Amgen | Meals · 2025-10-28 | Evenity | $22 |
| Otsuka America Pharmaceutical | Meals · 2025-10-07 | Rexulti | $30 |
| Astellas Pharma US | Meals · 2025-09-23 | Veozah | $28 |
| Sumitomo Pharma America | Meals · 2025-08-27 | Gemtesa | $25 |
| Lilly USA | Meals · 2025-08-05 | Mounjaro | $29 |
| Amgen | Meals · 2025-04-24 | Evenity | $133 |
See earlier years (2023, 2022, 2021)
2023: $58
| Kci USA | V.A.C. Dermatac | $46 | 2 payments
|
| Fisher & Paykel Healthcare | Fisher & Paykel Healthcare | $13 | 1 payment
|
2022: $96
| Novo Nordisk | Ozempic | $50 | 3 payments
|
| Kci USA | Activ.A.C. | $27 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $18 | 1 payment
|
2021: $103
| Novo Nordisk | Ozempic | $84 | 5 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $20 | 1 payment
|
Professional record
- NPI
- 1992211957
- Licence
- CA 95008024
- Group
- Urgent Care Plus Telehealth Inc · Providence Medical Foundation
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 3536 Mendocino Ave Ste 200, Santa Rosa, CA, 95403
- NPI first listed
- 2017-12-28
- NPI last updated
- 2021-10-20
- NPI record certified
- 2021-10-20
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.